Literature DB >> 19393988

Differential regulation of MMP-13 expression in two models of experimentally induced periodontal disease in rats.

Sabrina Garcia de Aquino1, Morgana Rodrigues Guimaraes, Dagmar Ruth Stach-Machado, Juliete Aparecida Francisco da Silva, Luís Carlos Spolidorio, Carlos Rossa.   

Abstract

OBJECTIVE: Evaluate expression of MMP-13 during the course of two models experimentally induced periodontal disease in rats.
DESIGN: Expression of MMP-13 at mRNA and protein levels was studied, respectively, by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. Two experimental models were used: LPS injections and ligature placement. 30mug of LPS from Eschericia coli was injected twice a week into the palatal aspect of upper molars. Ligatures were placed at the gingival margin around lower first molars. Controls received injections of PBS vehicle and no ligatures on lower molars. Samples were collected 5, 15 and 30 days after initiation of periodontal disease and processed for extraction of total RNA, total protein, and routinely processed for histology.
RESULTS: Both experimental models produced a significant increase on the inflammatory infiltrate that paralleled elevated levels of MMP-13 mRNA and protein at 5 and 15 days. The LPS model was associated with a sustained level of inflammation and increased MMP-13 mRNA throughout the 30 days, whereas the ligature model showed a decrease on the severity of inflammation and MMP-13 mRNA at the 30-day period. Interestingly, MMP-13 protein levels were diametrically contrary to the mRNA levels.
CONCLUSION: MMP-13 expression during LPS- and ligature-induced experimental periodontal disease follows the increase on severity of inflammation at the earliest periods. At 30 days, there is a decrease on the severity of inflammation on the ligature model associated with decreased MMP-13 mRNA. There is a lack of transcription-translation coupling of MMP-13 gene in both experimental models.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393988     DOI: 10.1016/j.archoralbio.2009.03.007

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  11 in total

1.  Curcumin modulates the immune response associated with LPS-induced periodontal disease in rats.

Authors:  Morgana R Guimarães; Sabrina Garcia de Aquino; Leila S Coimbra; Luis C Spolidorio; Keith L Kirkwood; Carlos Rossa
Journal:  Innate Immun       Date:  2011-01-17       Impact factor: 2.680

2.  Long-term evaluation of oral gavage with periodontopathogens or ligature induction of experimental periodontal disease in mice.

Authors:  Rafael Scaf de Molon; Vinicius Ibiapina Mascarenhas; Erica Dorigatti de Avila; Livia Sertori Finoti; Gustavo Boze Toffoli; Denise Madalena Palomari Spolidorio; Raquel Mantuaneli Scarel-Caminaga; Sotirios Tetradis; Joni Augusto Cirelli
Journal:  Clin Oral Investig       Date:  2015-09-28       Impact factor: 3.573

3.  Intragingival injection of Porphyromonas gingivalis-derived lipopolysaccharide induces a transient increase in gingival tumour necrosis factor-α, but not interleukin-6, in anaesthetised rats.

Authors:  Hiroko Taguchi; Yuri Aono; Takayuki Kawato; Masatake Asano; Noriyoshi Shimizu; Tadashi Saigusa
Journal:  Int J Oral Sci       Date:  2015-09-14       Impact factor: 6.344

Review 4.  Host response mechanisms in periodontal diseases.

Authors:  Nora Silva; Loreto Abusleme; Denisse Bravo; Nicolás Dutzan; Jocelyn Garcia-Sesnich; Rolando Vernal; Marcela Hernández; Jorge Gamonal
Journal:  J Appl Oral Sci       Date:  2015 May-Jun       Impact factor: 2.698

5.  Sirtuin 1 regulates matrix metalloproteinase-13 expression induced by Porphyromonas endodontalis lipopolysaccharide via targeting nuclear factor-κB in osteoblasts.

Authors:  Liu Qu; Yaqiong Yu; Lihong Qiu; Di Yang; Lu Yan; Jiajie Guo; Rabita Jahan
Journal:  J Oral Microbiol       Date:  2017-04-21       Impact factor: 5.474

6.  ZnO nanoparticles inhibit the activity of Porphyromonas gingivalis and Actinomyces naeslundii and promote the mineralization of the cementum.

Authors:  Jingyu Wang; Lele Du; Yingmei Fu; Peidong Jiang; Xiumei Wang
Journal:  BMC Oral Health       Date:  2019-05-14       Impact factor: 2.757

7.  The effects of morus nigra on the alveolar bone loss in experimentally-induced periodontitis.

Authors:  Tuba Talo Yildirim; Gonca Ozan; Serkan Dundar; Alihan Bozoglan; Tahir Karaman; Neval Dildes; Can Ayhan Kaya; Nalan Kaya; Elif Erdem
Journal:  Eur Oral Res       Date:  2019-09-01

8.  Silencing matrix metalloproteinase-13 (Mmp-13) reduces inflammatory bone resorption associated with LPS-induced periodontal disease in vivo.

Authors:  Morgana R Guimaraes-Stabili; Marcell Costa de Medeiros; Danuza Rossi; Angelo Constantino Camilli; Cleslei Fernando Zanelli; Sandro Roberto Valentini; Luis Carlos Spolidorio; Keith Lough Kirkwood; Carlos Rossa
Journal:  Clin Oral Investig       Date:  2020-11-02       Impact factor: 3.573

9.  Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF.

Authors:  Roosmarijn E Vandenbroucke; Eline Dejonckheere; Filip Van Hauwermeiren; Sofie Lodens; Riet De Rycke; Elien Van Wonterghem; An Staes; Kris Gevaert; Carlos López-Otin; Claude Libert
Journal:  EMBO Mol Med       Date:  2013-05-30       Impact factor: 12.137

10.  The effect of adjunctive low-dose doxycycline and licorice therapy on gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.

Authors:  Shirin Zahra Farhad; Atousa Aminzadeh; Morvarid Mafi; Mehrdad Barekatain; Mohammad Naghney; Mohammad Reza Ghafari
Journal:  Dent Res J (Isfahan)       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.